Position in NTRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,160,448
-$1,588,632 QoQ
Shares Held
4,275
-64.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#427
of 844 holders
Holding Since
Jun 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Derivatives in NTRA
reported options exposure · as of Jun 30, 2026CallValue
$38,003,000
CallShares
140,000
PutValue
$6,107,625
PutShares
22,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $5,547,975 across 3 Diagnostics & Research names. NTRA ranks #3 (20.9% of the industry book) .
All Filings in NTRA
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,003,000 | 140,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $1,160,448 | 4,275 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $6,107,625 | 22,500 | Put | Sole | 2026-08-14 | |
| 2025-12-31 | $2,749,080 | 12,000 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $7,602,300 | 45,000 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $8,279,090 | 52,300 | Put | Sole | 2025-02-14 | |
| 2024-06-30 | $3,669,731 | 33,888 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,573,000 | 50,000 | Put | Sole | 2024-05-15 | |
| 2023-03-31 | $4,164,000 | 75,000 | Call | Sole | 2023-05-15 | |
| 2022-09-30 | $1,424,150 | 32,500 | Put | Sole | 2022-11-14 | |
| 2022-09-30 | $1,310,218 | 29,900 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $2,135,700 | 52,500 | Call | Sole | 2022-05-13 | |
| 2021-06-30 | $3,065,310 | 27,000 | Call | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||